OS Therapies OSTX Income Statement (2023-2026)

NYSE OSTX
$1.58 +0.13 (+8.97%)
At close: Aug 20, 2026 · 4:00 PM EDT
Income Statement Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Shares Outstanding (Entity) (Quarter) 5.34M5.34M5.34M5.34M5.99M5.99M15.90M12.38M21.35M4.77M1.78M10.32M12.61M
Operating items
Research & Development (Quarter) 0.75M0.99M0.45M1.02M0.36M0.40M1.21M-1.88M2.50M3.76M-7.56M
Selling, General & Administrative (Quarter) 0.29M0.52M0.17M0.14M0.27M0.38M1.23M2.10M3.69M2.34M3.12M3.19M2.82M
Operating Expenses (Quarter) 1.05M1.52M0.62M1.16M0.63M0.78M2.44M0.21M3.69M4.84M6.88M-4.37M2.82M
Operating Income (Quarter) -1.05M-1.52M-0.62M-1.16M-0.63M-0.78M-2.44M-2.97M-5.00M-4.84M-6.88M-11.99M-10.17M
EBIT (Quarter) -1.05M-1.52M-0.62M-1.16M-0.63M-0.78M-2.44M-2.97M-5.00M-4.84M-6.88M-11.99M-10.17M
Non-operating items
Interest & Investment Income (Quarter) 1.001.0066.0064.0065.0054.0045.00
Other Non Operating Income (Quarter) 0.03M66.0064.0065.00-0.08M
Non Operating Income (Quarter) -0.80M-0.99M-1.35M-0.31M-0.83M-0.78M-0.44M-0.02M1.12M0.30M65.00-1.47M-0.23M
Net income details
EBT (Quarter) -1.85M-2.51M-1.97M-1.46M-1.72M-1.56M-2.88M-2.97M-5.00M-5.29M-7.38M-13.46M-10.32M
Profit After Tax (Quarter) -1.85M-2.51M-1.97M-1.46M-1.46M-1.56M-2.88M-2.99M-3.88M-4.54M-6.88M-13.46M-10.40M
Income from Continuing Operations (Quarter) -1.85M-2.51M-1.97M-1.46M-1.72M-1.56M-2.88M-2.97M-5.00M-5.29M-7.38M-13.46M-10.32M
Consolidated Net Income (Quarter) -1.85M-2.51M-1.97M-1.46M-1.72M-1.56M-2.88M-2.97M-5.00M-5.29M-7.38M-13.46M-10.32M
Income towards Parent Company (Quarter) -1.85M-2.51M-1.97M-1.46M-1.72M-1.56M-2.88M-2.97M-5.00M-5.29M-7.38M-13.46M-10.32M
Preferred Dividend Payments (Quarter) 0.03M0.03M0.03M0.03M0.03M
Net Income towards Common Stockholders (Quarter) -1.88M-2.54M-2.01M-1.50M-1.49M-1.56M-2.88M-2.99M-3.88M-4.54M-6.88M-13.46M-10.40M
Additional items
EPS (Basic) (Quarter) -0.37-0.47-0.38-0.28-0.26-0.26-0.18-0.24-0.31-0.95-3.87-1.30-0.82
EPS (Diluted) (Quarter) -0.47-0.38-0.28-0.25-0.26-0.18-0.43-0.18-0.18-0.22-0.46-0.27
Shares Outstanding (Quarter) 5.11M5.34M5.34M5.43M5.70M5.99M15.90M12.38M12.38M4.77M1.78M10.32M12.61M
Shares Outstanding (Diluted) (Quarter) 5.34M5.34M5.34M5.99M5.99M15.90M6.95M21.25M25.11M31.96M29.25M38.67M
EBITDA (Quarter) -1.05M-1.52M-0.62M-1.16M-0.63M-0.78M-2.44M-2.97M-5.00M-4.84M-6.88M-11.99M-10.17M
Interest Expenses (Quarter) 0.80M0.99M1.35M0.31M1.09M0.78M0.44M0.01M0.45M0.50M1.47M0.15M